Southan Christopher, Sharman Joanna L, Benson Helen E, Faccenda Elena, Pawson Adam J, Alexander Stephen P H, Buneman O Peter, Davenport Anthony P, McGrath John C, Peters John A, Spedding Michael, Catterall William A, Fabbro Doriano, Davies Jamie A
Centre for Integrative Physiology, University of Edinburgh, Edinburgh, EH8 9XD, UK.
School of Biomedical Sciences, University of Nottingham Medical School, Nottingham, NG7 2UH, UK.
Nucleic Acids Res. 2016 Jan 4;44(D1):D1054-68. doi: 10.1093/nar/gkv1037. Epub 2015 Oct 12.
The IUPHAR/BPS Guide to PHARMACOLOGY (GtoPdb, http://www.guidetopharmacology.org) provides expert-curated molecular interactions between successful and potential drugs and their targets in the human genome. Developed by the International Union of Basic and Clinical Pharmacology (IUPHAR) and the British Pharmacological Society (BPS), this resource, and its earlier incarnation as IUPHAR-DB, is described in our 2014 publication. This update incorporates changes over the intervening seven database releases. The unique model of content capture is based on established and new target class subcommittees collaborating with in-house curators. Most information comes from journal articles, but we now also index kinase cross-screening panels. Targets are specified by UniProtKB IDs. Small molecules are defined by PubChem Compound Identifiers (CIDs); ligand capture also includes peptides and clinical antibodies. We have extended the capture of ligands and targets linked via published quantitative binding data (e.g. Ki, IC50 or Kd). The resulting pharmacological relationship network now defines a data-supported druggable genome encompassing 7% of human proteins. The database also provides an expanded substrate for the biennially published compendium, the Concise Guide to PHARMACOLOGY. This article covers content increase, entity analysis, revised curation strategies, new website features and expanded download options.
《IUPHAR/BPS 药理学指南》(GtoPdb,http://www.guidetopharmacology.org)提供了成功药物和潜在药物与其人类基因组靶点之间经过专家整理的分子相互作用信息。该资源由国际基础与临床药理学联合会(IUPHAR)和英国药理学会(BPS)开发,其前身 IUPHAR-DB 在我们 2014 年的出版物中有过描述。此次更新纳入了在其间七个数据库版本中的变化。独特的内容获取模式基于既定的和新的靶点分类小组委员会与内部编辑人员的合作。大部分信息来自期刊文章,但我们现在也对激酶交叉筛选面板进行索引。靶点由 UniProtKB ID 指定。小分子由 PubChem 化合物标识符(CIDs)定义;配体获取还包括肽和临床抗体。我们扩展了通过已发表的定量结合数据(如 Ki、IC50 或 Kd)链接的配体和靶点的获取。由此产生的药理学关系网络现在定义了一个涵盖 7%人类蛋白质的数据支持的可成药基因组。该数据库还为每两年出版一次的简编《药理学简明指南》提供了扩展的基础资料。本文涵盖了内容增加、实体分析、修订的编辑策略、新的网站功能和扩展的下载选项。